'Hetao zone will boost HK's medical development'
Medical sector lawmaker David Lam said the Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone will help expedite medical development in the SAR, as he called for closer cross-boundary cooperation over the next five years. With Hong Kong preparing to come up with its first five-year plan, Lam said expanding clinical trials is key to turning the city into a major health and…
Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone aims to accelerate medical development in Hong Kong, according to lawmaker David Lam. With Hong Kong's population of 7.5 million compared to the 80 million in Greater Bay Area, bigger patient base will streamline clinical trials, leading to quicker drug registration.
Lam urges closer cross-border cooperation for the next five years, prioritizing research development, clinical trials and drug registration. Local universities and Hospital Authority can aid in R&D efforts and patient base expansion. The public consultation for Hong Kong's first five-year plan concludes in two months.
Written by urgent.news from RTHK English's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- 'Hetao zone will boost HK's medical development' news.rthk.hk
